General Information of the Compound
Compound ID
CP0181449
Compound Name
1-(3-Hydroxyphenyl)-4-propylpiperazine
    Show/Hide
Synonyms
1-(3-Hydroxyphenyl)-4-propylpiperazine
3-(4-Propyl-1-piperazinyl)phenol
AWROKCIGUWAVRF-UHFFFAOYSA-N
BDBM50308023
CHEMBL447809
SCHEMBL3453730
    Show/Hide
Structure
Formula
C13H20N2O
Molecular Weight
220.316
Canonical SMILES
CCCN1CCN(CC1)c1cccc(O)c1
    Show/Hide
InChI
InChI=1S/C13H20N2O/c1-2-6-14-7-9-15(10-8-14)12-4-3-5-13(16)11-12/h3-5,11,16H,2,6-10H2,1H3
    Show/Hide
InChIKey
AWROKCIGUWAVRF-UHFFFAOYSA-N
Physicochemical Property
logP
1.9242
Rotatable Bonds
3
Heavy Atom Count
16
Polar Areas
26.71
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 22397846
SID: 93371813
ChEMBL ID
CHEMBL447809
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
Ki = 69 nM
   TI
   LI
   LO
   TS
2
Ki = 721 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 1-(3-Hydroxyphenyl)-4-propylpiperazine )
Drug Name 1-(3-Hydroxyphenyl)-4-propylpiperazine
Target(s)
Dopamine D2 receptor (D2R)
Inhibitor